JPRN-UMIN000001349已完成4 期
Open-label randomized comparative study of cefepime vs. meropenem in adults with moderate to severe aspiration pneumonia - Cefepime vs. meropenem in moderate to severe aspiration pneumonia
Ono Municipal Hospital0 个研究点目标入组 120 人开始时间: 2008年9月30日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Hospital-acquired pneumonia (2) Hospitalization within 60 days prior to the development of the symptom(s) (3) Immunocompromising disease or receipt of immunopompromising therapy (4) Active lung cancer (5) Terminal illness (6) Pregnancy or breast-feeding (7) Known allergy to the indicated antibiotics (8) Other infiltrative diseases (e.g. radiation pneumonitis, organizing pneumonia, drug-induced pneumonia, obstructive pneumonia etc.) (9) Tuberculosis, fungal infection (10) Empyema
研究者
相似试验
已完成
4 期
Open-label randomized comparative study of cefepime vs. meropenem in adults with severe community-acquired pneumoniacommunity-acquired pneumoniaJPRN-UMIN000001352Ono Municipal Hospital40
已完成
不适用
A Multicenter Comparative Study of Cefepime Versus Broad-Spectrum Antibacterial Therapy in Moderate and Severe Bacterial InfectionsPER-032-99BRISTOL MYERS SQUIBB PERÚ S.A.,
已完成
4 期
Open-label randomized comparative study of cefotiam vs. ampicillin/sulbactam in adults with mild to moderate community-acquired pneumoniaCommunity-acquired pneumoniaJPRN-UMIN000001351Ono Municipal Hospital120
已完成
不适用
Effect of cefepime (CFPM) or meropenem (MEPM) for febrile neutropenia patients with lung cancer. Randomized phase II study.JPRN-UMIN000005275OGIK(Lung oncology group in Kyushu)46
已完成
1 期
Bioequivalence Study Between SKF101804 Cefixime 200 Milligram (mg)/5 Milliliter (mL) Suspension Versus Cefixime 200 mg/5 mL Suspension Reference Product in Healthy Adult Subjects Under Fasting ConditionsInfections, BacterialNCT03408392GlaxoSmithKline28